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Abstract
Background: The ankle brachial index (ABI) is an efficient tool for objectively documenting the presence of lower
extremity peripheral arterial disease (PAD). However, different methods exist for ABI calculation, which might result in
varying PAD prevalence estimates. To address this question, we compared five different methods of ABI calculation using
Doppler ultrasound in 6,880 consecutive, unselected primary care patients ≥65 years in the observational getABI study.
Methods:  In all calculations, the average systolic pressure of the right and left brachial artery was used as the
denominator (however, in case of discrepancies of ≥10 mmHg, the higher reading was used). As nominators, the
following pressures were used: the highest arterial ankle pressure of each leg (method #1), the lowest pressure (#2),
only the systolic pressure of the tibial posterior artery (#3), only the systolic pressure of the tibial anterior artery (#4),
and the systolic pressure of the tibial posterior artery after exercise (#5). An ABI < 0.9 was regarded as evidence of PAD.
Results: The estimated prevalence of PAD was lowest using method #1 (18.0%) and highest using method #2 (34.5%),
while the differences in methods #3–#5 were less pronounced. Method #1 resulted in the most accurate estimation of
PAD prevalence in the general population. Using the different approaches, the odds ratio for the association of PAD and
cardiovascular (CV) events varied between 1.7 and 2.2.
Conclusion: The data demonstrate that different methods for ABI determination clearly affect the estimation of PAD
prevalence, but not substantially the strength of the associations between PAD and CV events. Nonetheless, to achieve
improved comparability among different studies, one mode of calculation should be universally applied, preferentially
method #1.
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Background
The prevalence of peripheral arterial disease (PAD) is ris-
ing since life expectancy is steadily increasing. Intermit-
tent claudication (IC) as a classical manifestation of PAD
becomes evident in only a fraction of the affected patients,
thus demonstrating that the course is predominantly
asymptomatic [1,2]. The clinical importance of the early
identification of PAD as a manifestation of generalised
atherothrombotic disease has been increasingly acknowl-
edged in the recent years: although limb loss is a rare event
in patients with intermittent claudication [3], the pres-
ence of PAD is a powerful predictor of future cardiovascu-
lar and cerebrovascular events and of increased mortality
[4-7]. In primary health care, history taking and physical
examination are still the major tools for the diagnosis of
PAD, which leads to substantial under-diagnosis of the
disease [8,9]. Further, the positive predictive value of
intermittent claudication or diminished peripheral pulses
seems not be sufficiently high [10,11].
The ankle brachial index (ABI) offers a simple and effec-
tive method of objectively documenting the functional
state of the circulation in the lower limb and thus for the
diagnosis of lower extremity PAD. The measurement of
ABI can be performed in general practice using inexpen-
sive equipment and is an efficient tool which improves
the quality and efficiency of primary care with regard to
PAD [12,13]. A normal ABI, indicating good blood flow
to the extremity, is around 1.1 [14]. However, in a patient
with compromised perfusion of the lower limb, the index
is much lower than this. In this case, an ABI below 0.9 is
routinely found, and an index below 0.4 indicates severe
ischaemic symptoms [15]. Compared to angiography, an
ABI less than 0.9 is 90% sensitive and 98% specific for a
stenosis of 50% or more in leg arteries [13,16] and,
among well-trained operators, the test-retest reliability is
excellent [12, 17].
Assessment of ABI is performed by dividing the ankle
systolic pressure by the highest brachial systolic pressure
[15]. While this procedure allows various possibilities for
calculating the ABI, only one mode of calculation is rec-
ommended by experts [18]. It appears predictable that dif-
ferent modes of ABI calculation result in different PAD
prevalence estimates. Up to now, however, how the differ-
ent modes of ABI calculation affect the PAD prevalence
estimates and the association of PAD with other concur-
rent manifestations of atherothrombotic disease have not
been systematically investigated.
Methods
Ethics
The protocol of the German Epidemiological Trial on
Ankle Brachial Index (getABI) was approved by the Ethics
Committee of the University of Heidelberg in 2001. All
participating patients gave written informed consent. The
study was conducted according to the 'Good Epidemio-
logical Practice' recommendations issued by the 'German
Working Group Epidemiology' [19].
Study design
The (getABI) study is a large-scale epidemiological study
with a cross-sectional and longitudinal part. Results
reported in this paper refer to the cross-sectional part only.
The methods and design of the study have been described
elsewhere in greater detail [20,21]. Briefly, the central
study co-ordinating centre selected 34 vascular physicians
on the basis of their expertise in PAD. These vascular phy-
sicians, serving as centres of excellence, were evenly dis-
tributed geographically nation-wide, and each suggested
on average 10 general practitioners to the central co-ordi-
nating centre. Appropriate statistical methods were used
to check that the distribution of the 344 GPs was repre-
sentative in terms of location (post codes) and education
(internists serving as GPs, and general physicians) for the
total number of approximately 56,000 primary care phy-
sicians in Germany. Several weeks before the start of the
study, in 34 regional meetings the centres of excellence
instructed the GPs and their support staff about the
requirements of the study and trained them in the clinical
measurements, focusing particularly on ABI assessment.
Patients
A prevalence assessment of primary care attendees, irre-
spective of their reason for seeing the doctor, was con-
ducted within a pre-specified week in October 2001. In
each practice, the gender and age category of all patients
attending the practice and seeing the doctor were recorded
in a log-file for each day of the week. The only exclusion
criterion was life expectancy < 6 months. A total of 20 (in
exceptional cases up to 25) eligible patients fulfilling the
inclusion criteria (age ≥65 years, patient being legally
competent and able to co-operate appropriately and pro-
viding written informed consent) were recruited, prefera-
bly as evenly as possible over this week in order to avoid
selection bias. The data management centre was notified
by fax about the inclusion of the patients on a daily basis.
The baseline visit with the initial study examinations as
specified below was to be performed within 6 weeks after
the recruitment week. Further investigations included
patient and medication history, physical examination and
central laboratory tests at entry. The medical history as
assessed at baseline included the following conditions:
cardiovascular diseases (i.e. myocardial infarction, angina
pectoris, revascularisation procedures), cerebrovascular
diseases (i.e. stroke, transitory ischaemic attacks, or revas-
cularisation procedures on the carotids), peripheral PAD
(i.e. a history with regard to gangrene or amputation
[minor and major form] of the lower extremities on
account of PAD, IC [pain in the calf muscles while walk-BMC Public Health 2007, 7:147 http://www.biomedcentral.com/1471-2458/7/147
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ing or during other exertion, which disappears within 10
min at rest], or revascularisation procedures on the
peripheral arteries). In addition, the patients completed
the WHO Rose questionnaire on intermittent claudica-
tion [22].
Determination of ankle brachial index
During 34 regional study workshops the GPs were specif-
ically trained by certified specialists in vascular medicine
(centres of excellence) to perform ABI measurements
under standardised conditions [20], using a Doppler
ultrasonic device (Kranzbühler 8 MHz, Solingen, Ger-
many). The blood pressure cuff was used to measure
systolic blood pressure in the brachial artery in both arms
by use of the Doppler detector in the antecubital fossa. It
was then applied to the distal calf, and the Doppler probe
was used to determine systolic blood pressure at the left
and right posterior and anterior tibial arteries after a 5-
minute rest. Measurements were performed in supine
position with the upper body as flat as possible, since
measurements in the sitting or semi-sitting position may
result in a substantial increase in tibial artery blood pres-
sure. Calculation of the ABI was based on the following
methods (see also Table 1): the highest arterial pressure of
each leg (either posterior tibial or anterior tibial artery
above the ankle; method #1), the lowest pressure (either
posterior tibial or anterior tibial artery above the ankle;
#2), only the systolic pressure of the tibial anterior artery
(#3), and only the systolic pressure of the tibial posterior
artery (#4). Furthermore, the ABI was also determined
after exercise, however, only in the tibial posterior artery
of each leg (#5). The ABI was calculated as follows: the ABI
for each leg equals the ratio of the respective ankle pres-
sure as determined by methods #1–#5 to the average of
the right and left brachial artery pressures, unless there is
a discrepancy of 10 mmHg in blood pressure values
between the two arms. In such a case, the higher reading
was used for the ABI. For the further analyses, the higher
of the two ABI values obtained from the left and the right
ankle was used.
Determination of PAD
An ABI < 0.90 in either leg was considered as evidence of
PAD for all five determination methods. However, the
classification of patients according to the ABI was modi-
fied as follows: patients with an ABI > 1.5 and no history
of peripheral revascularisation and/or amputation on
account of PAD were excluded from the analysis. An ABI
of 1.5 or higher is consistent with poorly compressible leg
arteries and is unreliable for gauging arterial perfusion
accurately. Additionally, patients with a history of periph-
eral vascular revascularisation and/or limb amputation
and ABI values ≥0.9 were classified as PAD patients.
Statistical analysis
For the association between PAD status (determined using
the different modes of ABI calculation and using a cut off
value of 0.9) and the presence of cardiovascular events (in
the patient's history), odds ratios and sensitivities for the
'detection' of the history of cardiovascular events (with
corresponding specificities) were calculated. In addition,
the association between ABI (determined using the differ-
ent modes of calculation) and prevalent cardiovascular
events was described by receiver operating characteristic
(ROC) curves. Statistical analyses were performed with
SAS version 8.2 (SAS Institute Corp., Cary, NC, 1999).
Results
Description of the sample
A total of 27,486 patients aged 65 years or older (10,722
men and 16,764 women) were screened by their GP in the
recruitment week of the study. Only patients with written
informed consent could be included, and this was pro-
vided for this long-term study by only about one quarter
of patients (n= 6880). The age distribution of the patients
was consistent with the age distribution in Germany [23]
(Table 2). Compared to the patients screened, the percent-
age of recruited patients aged between 65 and 74 was
slightly higher, whereas that of patients aged ≥80 years
was somewhat lower. Thus, compared to the general pop-
ulation, the younger patients were over-represented in the
study, whilst the older were slightly under-represented
(Table 2). The gender distribution of included patients
was very similar to that of the general population in Ger-
many (not shown).
Prevalence estimates of PAD
The percentage of patients with symptomatic PAD was
9.2%, which included intermittent claudication (4.6%),
and/or positive Rose questionnaire (2.3%), and/or
peripheral event (2.3%).
Table 1: Description of the methods used for determination of 
the ankle-brachial index (ABI)
Method of ABI 
determination
Procedure (nominator in the ABI 
calculation)
#1 highest systolic pressure (tibial anterior/posterior 
artery)
#2 lowest systolic pressure (tibial anterior/posterior 
artery)
#3 only systolic pressure of tibial anterior artery
#4 only systolic pressure of tibial posterior artery
#5 after exercise (tibial posterior artery only)
The blood pressure measurements were performed on each leg as 
described in the methods section. The denominator in all calculations 
was the average of the right and left brachial arterial pressure (unless 
discrepancy of ≥10 mmHg, which led to the use of the higher 
pressure).BMC Public Health 2007, 7:147 http://www.biomedcentral.com/1471-2458/7/147
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As shown in Fig. 1, the PAD prevalence estimate was pro-
foundly affected by the mode of ABI calculation. While
method #1 yielded the lowest prevalence estimate
(18.0%), method #2 resulted in a value nearly double that
(34.5%). The differences between methods #3, #4 and #5
were less pronounced (29.0%, 24.2% and 27.8% respec-
tively).
Association between PAD and cardiac events
The association between PAD and cardiac events was
influenced by the mode of ABI determination when odds
ratios (OR) were used for the description of this associa-
tion. Cardiac events were classified as myocardial infarc-
tion or coronary revascularisation (n = 821 patients). As
demonstrated in Fig. 2, the univariate OR at the cut-off
point of 0.9 was highest in method #1 (2.2) and lowest in
method #2 (1.7). In methods #3–#5, the OR was 1.9 and
did not differ between the modes of ABI calculation. The
sensitivity for detection of a history of cardiac events was
highest in method #2 (46.1%) and lowest in method #3
(30.1%). In contrast, the specificity was highest in
method #1 (83.6%) and lowest in method #2 (67.1%). In
methods #3–#5, the respective sensitivities and specifici-
ties were in the same range and did not differ appreciably
between the ABI calculation methods.
However, using receiver operating characteristic (ROC)
methodology, the association between PAD according to
the different modes of ABI calculation and cardiac events
was nearly the same, with only slight differences between
the respective ROC curves (Fig. 3).
Discussion
Determination of ABI allows the non-invasive and relia-
ble detection and quantification of PAD. It is one of the
most widely used methods in the epidemiology of PAD
since it can be easily performed in large-scale studies, with
low variability of measurements between different observ-
ers [12,17,24]. At the same time, it is increasingly used as
screening measure in primary care. However, different
modes of ABI calculation are used in the literature. In
some reports, the highest arterial pressure in each leg is
used, whilst in others the lowest arterial pressure serves to
determine the ABI. Alternatively, only the tibialis poste-
rior or dorsalis pedis pressure is used, or the pressures of
one leg are averaged [18,24-27]. However, the optimal
method for ABI calculation for estimating the prevalence
of PAD and predicting mortality and other outcomes in
PAD has to our knowledge not been determined.
Association between PAD and history of cardiac event using  odds ratios (OR) Figure 2
Association between PAD and history of cardiac event using 
odds ratios (OR). PAD was defined by an ABI value < 0.9 or 
clinical evidence of PAD, while history of cardiac event was 
evident after myocardial infarction or coronary revascularisa-
tion. OR, sensitivity and specificity are shown for the differ-
ent modes of ABI calculation.  Sensitivity and specificity are 
given for the 'detection' or 'exclusion', resp., of a history of 
cardiac events.
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Table 2: Age distribution of screened and included patients 
compared with the age distribution in Germany within the 
respective age categories
Age 
category 
(years)
Age 
distribution in 
Germany (%)
Patients screened 
for getABI (%)
Patients included 
in getABI (%)
65–69 30.1 30.9 34.6
70–74 26.6 26.5 32.1
75–79 21.4 20.0 21.7
80–84 9.7 13.3 9.4
≥85 12.2 9.3 2.2
Source for age distribution in Germany: [23].
Prevalence estimates for PAD using different methods for  ABI calculation Figure 1
Prevalence estimates for PAD using different methods for 
ABI calculation. PAD was defined by an ABI value < 0.9 (grey 
bars) or clinical evidence of PAD (black bars). Clinical evi-
dence of PAD included positive Rose questionnaire, intermit-
tent claudication and peripheral vascular event.
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This is the first large-scale epidemiological study to screen
an unselected sample of patients in primary care for the
prevalence of PAD using different methods for the calcu-
lation of the ABI. The data confirm the high prevalence of
PAD in primary care [28,29], indicating that – at least –
about every fifth subject aged ≥65 years, is a PAD patient.
In our study, and as recommended by the American Heart
Association [30], taking the higher of the two systolic
pressures (method #1, tibial posterior and anterior artery)
resulted in the most conservative estimate of the preva-
lence of PAD. However, at ABI values > 1.5, the presence
of poorly compressible ankle arteries due to calcified ves-
sels should be taken into account. Incompressible arteries
are frequently observed in diabetics and haemodialysis
patients and may result in incorrectly high ABI values
[31].
Modes of ABI calculations in which the dorsalis pedis
(which is the distal extension of the anterior tibial artery)
pressure (method #3) serves as the numerator may be
misleading and not generally suitable in primary care,
since an absent dorsalis pedis signal due to hypoplasia is
described in 8–12% of healthy subjects without PAD
[11,32]. The smaller diameter of the dorsalis pedis artery
relative to the posterior tibial artery may be more difficult
for general physicians to locate with the Doppler probe
(leading to an underestimate of the true pressure), and in
addition, artery pressures due to pulse wave reflection in
smaller vessels may be different in the two vessels. [14]
Thus, if the numerator were defined by the dorsalis pedis
pressure (method #3) or the lowest ankle pressure
(method #2) (which would be 0 if the dorsalis pedis pres-
sure is not detectable), the value 0 would be attributed to
these legs although PAD would be absent. Likewise, in a
smaller study in healthy subjects, Aboyans et al. [26] dis-
qualified methods involving the lower arterial pressure at
the ankle, since this method cannot distinguish between
hypoplastic or obstructed arteries. As in our approach,
that study also recommended the use of the higher arterial
pressure at the ankle for calculation of the ABI, which
yielded a PAD prevalence estimate of about 5% at the cut-
off point of 0.9. This lower value can be explained by the
fact that patients with history of PAD were excluded in the
study by Aboyans et al. Moreover, the cohort was signifi-
cantly younger, with only 26% of the patients being > 65
years [26].
In another approach, McDermott et al. correlated three
modes of ABI determination to leg functioning parame-
ters in PAD patients [33]. As in the present observations,
using the lower of the two arterial pressures at the ankle
(method #2) resulted in a significantly higher PAD preva-
lence. However, their results suggested that the ABI, deter-
mined by averaging the dorsalis pedis and posterior tibial
arterial pressures in each leg, may be most predictive of
walking endurance and walking speed in patients with
peripheral arterial disease. In contrast to that study, which
was performed with regard to leg functioning parameters
on selected patients with high prevalence of PAD, the
present investigation was performed on a large-scale gen-
eral population aged 65 years or older. Consequently, the
results may not be directly comparable.
Another finding is of considerable importance for the
practical use of the ABI for screening purposes. While the
different modes of ABI calculation profoundly affected
the estimation of PAD prevalence, there was no major
effect on the association between other concomitant man-
ifestations of atherothrombotic disease, i.e. cardiovascular
events. ROC analyses were performed to describe the rela-
tionship between sensitivity and specificity of different
ABI values (according to different modes of calculation)
with respect to history of cardiovascular events. Interest-
ingly, the respective ROC curves differed only marginally
between the diverse modes of calculation, indicating that
the strength of association between the ABI and cardiovas-
cular events is largely independent of the mode of ABI
determination. Thus, an abnormal ABI, irrespective of the
mode of calculation, is associated with the same preva-
ROC curves for the association between ABI values (accord- ing to different methods for ABI calculation) and the history  of cardiovascular events (myocardial infarction or coronary  revascularisation) Figure 3
ROC curves for the association between ABI values (accord-
ing to different methods for ABI calculation) and the history 
of cardiovascular events (myocardial infarction or coronary 
revascularisation). Black line, method #1; red line, method #2; 
yellow line, method #3; green line, method #4. The red dashed 
line represents the line of identity of tpr and fpr.
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lence of cardiovascular events at a "mode-specific" cut-off
point.
For the assessment of exercise ABI, in contrast to a previ-
ous methodological study [14] that used the posterior tib-
ial artery or the dorsalis pedis artery (which is the distal
extension of the anterior tibial artery), due to the reasons
given above [14,32] we chose to focus on measurements
on one vessel, the posterior tibial artery. Of note, even the
determination of the ABI after exercise did not increase
the strength of association with concurrent (or history of)
cardiovascular events. Since ABI calculation after exercise
is a demanding procedure in terms of time and man-
power, and since there is no obvious advantage over other
methods, this approach may not be suitable for routine
determination of the ABI in general practice.
Conclusion
To summarise, for improved comparability of data in epi-
demiological and clinical studies employing the ABI, one
mode of ABI calculation should be universally used. As
previously suggested by the American Heart Association,
taking the higher of the two arterial pressures at the ankle
may be the most suitable procedure for ABI determination
in primary care.
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